AB
Amish Bipinchandra Shah
About Amish Bipinchandra Shah
Data last updated:
Amish Bipinchandra Shah has 22 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 5 companies, including Aadivighnesh Chem Private Limited and Innovative Speciality Ingredients Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Aadivighnesh Chem Private Limited U51397MH2004PTC147379 | Director | 08 Jul 2004 | 2004 | Active |
| Innovative Speciality Ingredients Private Limited U74120MH2013PTC244057 | Director | 05 Jun 2013 | 2013 | Active |
 Ahepra Healthcare Private Limited U85100MH1995PTC084449 | Whole-Time Director | 01 Apr 2022 | 1995 | Active |
| Index Pharma Llp AAD-2048 | Designated Partner | 15 Jan 2015 | 2015 | Active |
| Ranchodray Developers Llp AAE-9100 | Partner | 12 Oct 2015 | 2015 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amish Bipinchandra Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amish Bipinchandra Shah
Amish Bipinchandra Shah has 22 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 5 companies, including Aadivighnesh Chem Private Limited and Innovative Speciality Ingredients Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Amish Bipinchandra Shah is associated with 5 companies as Director and Whole-Time Director.
Amish Bipinchandra Shah has expertise in General Business, Healthcare.
Amish Bipinchandra Shah has 22 years in corporate governance.